Steve Hoffmann

Steve Hoffmann is the Director, Inflammation and Immunity in Research Partnerships at the Foundation for the National Institutes of Health (FNIH). He provides strategic planning, programmatic management and research administration of a broad portfolio of established and emerging projects within the Biomarkers Consortium and Accelerating Medicines Partnership including projects in arthritis, rare diseases, organ toxicity, infectious disease and other autoimmune and inflammatory diseases.
Steve has a broad background in the academic, government and industry sectors in the field of translational biomarkers, molecular immunology and precision medicine. Prior to joining FNIH, Steve worked as both a project and product manager, supporting protein diagnostics development at Meso Scale Discovery (MSD). Before MSD, Steve was a scientist in the Transplantation and Autoimmunity Branch of the National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) and led research efforts utilizing immune depletion and co-stimulatory blockade strategies for human renal and islet cell transplant trials. Steve holds a Master of Science degree in Pathology and Laboratory Medicine from the University of North Carolina at Chapel Hill and a Bachelor of Science degree in Biochemistry and Biophysics from the University of Pittsburgh.